HER2 Positive or Suspicious Positive Tumors
2 clinical trials · Condition
◉ Watch HER2 Positive or Suspicious Positive Tumors
| Record | Firm | Date |
|---|---|---|
| HER2 Expression of HER2 Affibody-based PET/CT to Predict Response in Bladder Cancer Patients Treated With ADC (NCT06548529) | Peking University Cancer Hospital & Institute | 2024-06-01 |
| Research for the Molecular Imaging of the HER2 Targeting Tracer (NCT04547309) | Peking University Cancer Hospital & Institute | 2020-09-07 |
Track HER2 Positive or Suspicious Positive Tumors automatically
Every clearance here is in the API, with alerts when new ones post.